Enabio Materials
英华辰睿
Enabio Materials (英华辰睿) is a biomaterials startup focused on high-performance modification and application innovation for bio-based materials . Founded in August 2022, the company has built a technical team where R&D staff account for over 60% of headcount . Its core capability lies in proprietary multi-step continuous reaction compatibilization and other unique modification techniques that boost crystallinity and melt strength, opening downstream applications in fibers, non-woven fabrics, lamination, and high-speed 3D printing .
The company raised tens of millions of RMB in an angel round led by Linear Capital in December 2023, with Bluepha (蓝晶微生物) as co-investor . Founder Zhou Zhen (周祯) has described the firm's mission as solving industry bottlenecks through distinctive modification technology and processing expertise . By late 2025, Enabio was being positioned by Linear Capital as an AI4S (AI for Science) portfolio company, with Zhou participating in investor forums on molecular discovery and materials science alongside AI-driven drug development peers .
AI-generated — may contain errors, please verify.
Coverage
Where Are the Opportunities for China's AI4S Industry in Trump's "Genesis Project"? | Linear Voice
Standing at the historical inflection point of a new Age of Scientific Discovery.
线性资本·Linear Capital's 2025 Investor Conference Successfully Held in Beijing | Linear News
To be or not to be, in the AI-dominated future.
线性资本·Taking Gems From Fire — Linear Capital's 2024 Year in Review
2024 is coming to a close. I'd like to borrow the theme from our annual meeting in October to summarize this year: *Taking Gems From Fire* — a fitting description of Linear Capital's work this past year.
线性资本·Linear Capital | Linear Path, Nonlinear Growth
Striving to become China's best frontier tech and innovation fund.
线性资本·"Yinghua Chenrui" Zhou Zhen: Solving Biomaterial Industry Bottlenecks with Unique Modification Technology and Processing Techniques | Linear Capital Portfolio Interview Series
In late December 2023, bio-based materials high-performance modification and application innovation company **Yinghua Chenrui** announced the completion of a tens of millions of RMB angel funding round.
线性资本·Linear Capital's 2023 Retrospective: Moving Forward Through Challenges
In September 2023, [when summarizing Linear Capital's ninth anniversary, we wrote this line: the goal lies far ahead, the road remains difficult, but there is light in our hearts](https://mp.weixin.qq.com/s?__biz=MzAwNTAyMDAyNQ==&mid=2652305248&idx=1&sn=eb922534db0722f5ef06117e
线性资本·Bio-materials high-performance modification and application innovation company "Yinghua Chenrui" raises tens of millions of RMB in angel funding, led by Linear Capital
Output high-performance bio-based material modification capabilities.
线性资本·






